Security key
92941V308
VYNE Therapeutics Inc. - Common Stock, par value $0.0001 (VYNE)
CUSIP: 92941V308
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common Stock, par value $0.0001
- Shares outstanding
- 33,333,333
- Total 13F shares
- 8,179,397
- Share change
- +2,809,841
- Total reported value
- $4,743,526
- Price per share
- $0.58
- Number of holders
- 39
- Value change
- +$1,869,192
- Number of buys
- 19
- Number of sells
- 10
Report period
Q4 2025
Institutions
39
Top holders
10
VYNE full security history
Newer quarter: Q1 2026
Previous quarter: Q3 2025
VYNE Therapeutics Inc. SEC filings
VYNE Therapeutics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92941V308
Recent filing periods:
Top shareholders of VYNE - VYNE Therapeutics Inc. - Common Stock, par value $0.0001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| CITADEL ADVISORS LLC |
13D/G
|
Kenneth Griffin |
0.01%
|
3,732
|
$1,250 | -$367,360 | 30 Sep 2025 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
2.6%
|
851,353
|
$285,203 | — | 30 Sep 2025 | |
| ACORN CAPITAL ADVISORS, LLC |
13F
|
Company |
1.8%
|
586,572
|
$199,434 | — | 30 Sep 2025 | |
| Shay Capital LLC |
13F
|
Company |
1.5%
|
492,577
|
$165,013 | — | 30 Sep 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
1.3%
|
446,414
|
$148,000 | — | 30 Sep 2025 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.87%
|
290,000
|
$97,149 | — | 30 Sep 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.66%
|
220,788
|
$73,964 | — | 30 Sep 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.57%
|
190,383
|
$63,778 | — | 30 Sep 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.44%
|
147,120
|
$49,285 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.41%
|
137,122
|
$45,938 | — | 30 Sep 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.32%
|
106,459
|
$35,664 | — | 30 Sep 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.23%
|
76,958
|
$25,781 | — | 30 Sep 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.17%
|
57,763
|
$19,351 | — | 30 Sep 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.17%
|
56,600
|
$18,961 | — | 30 Sep 2025 | |
| CORSAIR CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
0.15%
|
50,000
|
$16,750 | — | 30 Sep 2025 | |
| Rangeley Capital, LLC |
13F
|
Company |
0.15%
|
50,000
|
$16,750 | — | 30 Sep 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.13%
|
44,404
|
$14,875 | — | 30 Sep 2025 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.11%
|
35,921
|
$12,000 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.07%
|
23,110
|
$7,742 | — | 30 Sep 2025 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.05%
|
18,298
|
$6,000 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.05%
|
15,765
|
$5,281 | — | 30 Sep 2025 | |
| Harvest Investment Services, LLC |
13F
|
Company |
0.03%
|
11,059
|
$3,705 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
5,572
|
$1,866 | — | 30 Sep 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
3,597
|
$1,205 | — | 30 Sep 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
2,440
|
$1,000 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
1,532
|
$513 | — | 30 Sep 2025 | |
| MB, LEVIS & ASSOCIATES, LLC |
13F
|
Company |
0%
|
1,041
|
$349 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
911
|
$305 | — | 30 Sep 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
146
|
$49 | — | 30 Sep 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
65
|
$22 | — | 30 Sep 2025 | |
| Truvestments Capital LLC |
13F
|
Company |
0%
|
25
|
$8 | — | 30 Sep 2025 | |
| Newbridge Financial Services Group, Inc. |
13F
|
Company |
0%
|
10
|
$3 | — | 30 Sep 2025 | |
| PERCEPTIVE ADVISORS LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
4,935,057
|
$11,251,930 | — | 16 Aug 2021 | |
| AI Biotechnology LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,116,585
|
$2,545,814 | — | 01 Nov 2023 | |
| Andrew Saik |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
116,468
|
$265,547 | — | 28 May 2021 | |
| Matthew T. Wiley |
3/4/5
|
Chief Commercial Officer |
—
class O/S missing
|
109,246
|
$249,081 | — | 30 Jun 2021 | |
| Patrick G. Lepore |
3/4/5
|
Director |
—
mixed-class rows
|
71,472
mixed-class rows
|
$150,298 | — | 12 Dec 2025 | |
| STALEY CAPITAL ADVISERS INC |
13F
|
Company |
—
class O/S missing
|
51,472
|
$17,243 | — | 30 Sep 2025 | |
| Fortitude Family Office, LLC |
13F
|
Company |
—
class O/S missing
|
680
|
$228 | — | 30 Sep 2025 | |
| Farther Finance Advisors, LLC |
13F
|
Company |
—
class O/S missing
|
16
|
$5 | — | 30 Sep 2025 | |
| Rex Bright |
3/4/5
|
Director |
—
class O/S missing
|
20,500
|
— | — | 19 Jul 2021 | |
| Anthony D. Bruno |
3/4/5
|
Director |
—
class O/S missing
|
20,000
|
— | — | 12 Dec 2024 | |
| Christine Borowski |
3/4/5
|
Director |
—
class O/S missing
|
20,000
|
— | — | 12 Dec 2024 | |
| Elisabeth Sandoval Little |
3/4/5
|
Director |
—
class O/S missing
|
20,000
|
— | — | 12 Dec 2025 | |
| Sharon Barbari |
3/4/5
|
Director |
—
class O/S missing
|
20,000
|
— | — | 12 Dec 2025 | |
| Steven L. Basta |
3/4/5
|
Director |
—
class O/S missing
|
20,000
|
— | — | 12 Dec 2025 |
Institutional Holders of VYNE Therapeutics Inc. - Common Stock, par value $0.0001 (VYNE) as of Q4 2025
As of 31 Dec 2025,
VYNE Therapeutics Inc. - Common Stock, par value $0.0001 (VYNE) was held by
39 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,179,397 shares.
The largest 10 holders included
Shay Capital LLC, Anson Funds Management LP, Nantahala Capital Management, LLC, T3 Companies, LLC, ACADIAN ASSET MANAGEMENT LLC, KVP Capital Advisors, LP, VANGUARD GROUP INC, Ikarian Capital, LLC, ADAR1 Capital Management, LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
39
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
31
Q4 2025 holders
39
Holder diff
8
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.